Jump to Navigation

Facebook Connect

User login

Ancillary Course Info

REGISTER TODAY!

The NLA's Lipid Academy provides a comprehensive, in-depth introduction to lipid science and is open to all health care professionals interested in developing a core competency in the diagnosis and treatment of dyslipidemia. The interactive Lipid Academy course provides health professionals with the knowledge and tools necessary to work effectively in a lipid practice, and will serve as the foundation for advanced lipid training.

The Lipid Academy is offered as a 2-day course prior to each scientific meeting conducted by the NLA.

Course Curriculum

  • Lipids, Lipoproteins and Atherosclerosis
  • Landmark Clinical Trials
  • Primary Literature Evaluation and Discussion
  • Diagnosis and Clinical Appraisal
  • Pharmacologic Therapies
  • Therapeutic Lifestyle Changes
  • Overview of Clinical Guidelines in Lipid Management
  • Challenging Patient Cases

    
Target Audience
This activity is designed to meet the needs of physicians, physician assistants, pharmacists, registered nurses, advance practice registered nurses, nurse practitioners and registered dietitians with an interest in lipid management.

Upon completion of the educational activity, participants should be able to:

  1. Analyze case studies in lipid management to improve treatment and prevention of cardiovascular disease
  2. Analyze lipid cases for health professionals seeing patients with complex disorders
  3. Apply basic principles of statistics to enhance understanding of clinical trials related to lipid management
  4. Assess the side effects of lipid-altering drugs to encourage their safe use in cardiovascular disease prevention
  5. Compare and contrast the effectiveness of available risk assessment instruments and markers in predicting CV risk in all population groups.
  6. Compose a clinical care plan for reducing risk of CVD in patients with dyslipidemia.
  7. Describe effective diet and lifestyle strategies for long-term obesity and dyslipidemia management
  8. Describe the appropriate use of lipid-altering drugs in special populations
  9. Describe the association of specific dietary patterns such as increased sodium and sugar intake, and the increased risk for cardiovascular disease associated morbidity and mortality.
  10. Describe the functions and sources of cholesterol and triglycerides, and the role of lipoproteins in atherosclerosis.
  11. Discuss clinical trials and their role in lipid and lipoprotein treatment in cardiovascular prevention.
  12. Explain the pathogenesis of atherosclerosis.
  13. For Registered Nurses and Nurse Practitioners Only: Provide appropriate care and counsel for patients and their families
  14. Identify primary and secondary causes of dyslipidemia
  15. Identify the management of dyslipidemia in special populations based on gender, culture, and disease variables;
  16. Identify the role of inflammation in atherogenesis
  17. Outline current guidelines on the diagnosis, management and treatment of patients with dyslipidemia;
  18. Recognize the role of drug therapy in the management of dyslipidemia.
  19. Review the clinical trials of lipid-altering drug therapies used in cardiovascular disease prevention
  20. Review the mechanism of action, pharmacokinetics, and efficacy of available FDA approved drugs for the management of lipid disorders

The National Lipid Association is accredited by the American Nurses Credentialing Center (ANCC), the Accreditation Council for Pharmacy Education (ACPE), and the Accreditation Council for Continuing Medical Education (ACCME), to provide continuing education for the healthcare team.

Physician Credit Designation Statement
The National Lipid Association designates this live activity for a maximum of 13.50 AMA PRA Category 1 Credit(s). Physicians should claim only credit commensurate with the extent of their participation in the activity.

Physician Assistants
NCCPA accepts AMA PRA Category I Credit™ from organizations accredited by ACCME.

Dietitians
The National Lipid Association is a Continuing Professional Education (CPE) Accredited Provider with the Commission on Dietetic Registration (CDR). Registered dietitians (RDs) and dietetic technicians, registered (DTRs) will receive 13 continuing professional education units (CPEUs) for completion of this program/ materials. CDR Accredited Provider #NL0002.

CE Credit provided by The National Lipid Association
Pharmacists
The National Lipid Association is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
Day 1 Morning Session - Universal Activity Number - 0624-0000-17-013-L01-P (Knowledge)
The National Lipid Association designates this continuing education activity for 3.25 contact hour(s) (.325 CEUs) of the Accreditation Council for Pharmacy Education.
Day 1 Afternoon Session - Universal Activity Number - 0624-0000-17-014-L01-P (Knowledge)
The National Lipid Association designates this continuing education activity for 4.25 contact hour(s) (.425 CEUs) of the Accreditation Council for Pharmacy Education.
Day 2 Morning Session - Universal Activity Number - 0624-0000-17-015-L01-P (Knowledge)
The National Lipid Association designates this continuing education activity for 4.00 contact hour(s) (.40 CEUs) of the Accreditation Council for Pharmacy Education.
Day 2 Afternoon Session - Universal Activity Number - 0624-0000-17-016-L01-P (Application)
The National Lipid Association designates this continuing education activity for 2.25bcontact hour(s) (.225 CEUs) of the Accreditation Council for Pharmacy Education.

Nursing
This educational activity for 13.5 contact hours is provided by The National Lipid Association.
The National Lipid Association is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.
Day 1 Morning Session- 3.1 credits; Day 1 Afternoon Session- 4.2 credits; Day 2 Morning Session- 4 credits; Day 2 Afternoon Session- 2.2 credits.
Pharmacotherapy contact hours for Advance Practice Registered Nurses to be determined.

Criteria for Success
Statements of credit will be awarded based on the participant's attendance and submission of the activity evaluation form. A statement of credit will be available upon completion of an online evaluation/ claimed credit form at www.lipid.org/cme.

For Pharmacists:
Upon receipt of the completed activity evaluation form, transcript information will be available at www.mycpemonitor.net within 4 weeks.

Disclosure Statement
It is the policy of NLA to ensure independence, balance, objectivity, scientific rigor, and integrity in all of its continuing education activities. The faculty must disclose to the participants any significant relationships with commercial interests whose products or devices may be mentioned in the activity or with the commercial supporter of this continuing education activity. Identified conflict of interest is resolved by NLA prior to accreditation of the activity. NLA planners and reviewers have no relevant financial relationships to disclose.

Commercial Support
Full notification of commercial support will be provided in the activity syllabus.

Joseph J. Saseen, PharmD, CLS, FNLA

Chair
Professor
Clinical Pharmacy and Family Medicine
University of Colorado Denver
Anschutz Medical Campus
Aurora, CO

Daniel E. Soffer, MD, FNLA

Chair
University of Pennsylvania Health System
Internal Medicine/Clinical Lipidology
Perelman Center for Advanced Medicine
Philadelphia, PA

Lori Alexander, MSHS, RD, CCRC, CLS, FNLA

Site Manager    
St. Johns Center for Clinical Research     
Ponte Vedra, FL

Ann Liebeskind, MD, FAAP

Founder, Complex Lipids Clinic
Mobile Health Team
Neenah & Wauwautosa, WI 

Pamela B. Morris, MD, FNLA

Director, Preventive Cardiology
Co-Director, Women’s Heart Care
Medical University of South Carolina
Mt. Pleasant, SC

2017 Lipid Academy at Fall Clinical Lipid Update- Indianapolis

Thursday, August 10, 2017

Day 1

8:00 - 8:35 AM Registration & Breakfast
8:35 - 10:05 AM Atherosclerosis, Lipids and Lipoproteins Daniel E. Soffer, MD, FNLA
10:05 - 10:20 AM Break
10:20 - 11:50 AM Landmark Clinical Trials Joseph J. Saseen, PharmD, CLS, FNLA
11:50 - 12:35 Lunch
12:35 - 2:05 PM Diagnosis and Clinical Appraisal Daniel E. Soffer, MD, FNLA
2:05 - 2:20 PM Break
2:20 - 3:50 PM Pharmacologic Therapies Joseph J. Saseen, PharmD, CLS, FNLA
3:50 - 4:50 PM Primary Literature Evaluation and Discussion Joseph J. Saseen, PharmD, CLS, FNLA Daniel E. Soffer, MD, FNLA
4:50 - 5:05 PM Q &A

Friday, August 11, 2017

Day 2

7:30 - 8:00 AM Breakfast
8:00 - 9:15 AM Overview of Clinical Guidelines and Recommendations in Lipid Management Pamela B. Morris, MD, FNLA
9:15 - 10:30 AM Pediatrics and Lipid Disorders in Women Ann M. Liebeskind, MD, FAAP
10:30 - 10:45 AM Break
10:45 - 12:15 Therapeutic Lifestyle Changes Lori Alexander, MSHS, RD, CLS, FNLA
12:15 - 12:45 PM Lunch
12:45 - 1:20 PM Challenging Patient Cases- Combination Therapy in High Risk Patient Presenter: Pamela B. Morris, MD, FNLA Panelists: Joseph J. Saseen, PharmD, CLS, FNLA Daniel E. Soffer, MD, FNLA Lori Alexander, MSHS, RD, CLS, FNLA Ann M. Liebeskind, MD
1:20 - 1:55 PM Challenging Patient Cases- Primary Prevention in Women Presenter: Ann M. Liebeskind, MD Panelists: Joseph J. Saseen, PharmD, CLS, FNLA Daniel E. Soffer, MD, FNLA Lori Alexander, MSHS, RD, CLS, FNLA Pamela B. Morris, MD, FNLA
1:55 - 2:30 PM Challenging Patient Cases- Hyperchylomicronemia Syndrome Presenter: Lori Alexander, MSHS, RD, CLS, FNLA Panelists: Joseph J. Saseen, PharmD, CLS, FNLA Daniel E. Soffer, MD, FNLA Ann M. Liebeskind, MD Pamela B. Morris, MD, FNLA
2:30 - 3:00 PM Panel Discussion with Q&A



by Dr. Radut.